Literature DB >> 31389297

A mechanistic modelling approach for the determination of the mechanisms of inhibition by cyclosporine on the uptake and metabolism of atorvastatin in rat hepatocytes using a high throughput uptake method.

Simon J Carter1, Alex S Ferecskó2, Lloyd King2, Karelle Ménochet2, Ted Parton3, Michael J Chappell1.   

Abstract

Determine the inhibition mechanism through which cyclosporine inhibits the uptake and metabolism of atorvastatin in fresh rat hepatocytes using mechanistic models applied to data generated using a high throughput oil spin method.Atorvastatin was incubated in fresh rat hepatocytes (0.05-150 nmol/ml) with or without 20 min pre-incubation with 10 nmol/ml cyclosporine and sampled over 0.25-60 min using a high throughput oil spin method. Micro-rate constant and macro-rate constant mechanistic models were ranked based on goodness of fit values.The best fitting model to the data was a micro-rate constant mechanistic model including non-competitive inhibition of uptake and competitive inhibition of metabolism by cyclosporine (Model 2). The association rate constant for atorvastatin was 150-fold greater than the dissociation rate constant and 10-fold greater than the translocation into the cell. The association and dissociation rate constants for cyclosporine were 7-fold smaller and 10-fold greater, respectively, than atorvastatin. The simulated atorvastatin-transporter-cyclosporine complex derived using the micro-rate constant parameter estimates increased in line with the incubation concentration of atorvastatin.The increased amount of data generated with the high throughput oil spin method, combined with a micro-rate constant mechanistic model helps to explain the inhibition of uptake by cyclosporine following pre-incubation.

Entities:  

Keywords:  Mechanistic modelling; atorvastatin; competitive inhibition; cyclosporine; high throughput; inhibition mechanism; metabolism; micro-rate constant; non-competitive inhibition; rat hepatocyte uptake

Mesh:

Substances:

Year:  2019        PMID: 31389297     DOI: 10.1080/00498254.2019.1652781

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  1 in total

1.  Prediction of Clinical Transporter-Mediated Drug-Drug Interactions via Comeasurement of Pitavastatin and Eltrombopag in Human Hepatocyte Models.

Authors:  Simon J Carter; Bhavik Chouhan; Pradeep Sharma; Michael J Chappell
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.